Mark Your Calendars: A Must-Attend Symposium on LM
We’re excited to announce that CNSide Diagnostics will participate in the upcoming 2025 SNO/ASCO CNS Metastases Conference, held in Baltimore, Maryland.
Date & Time: Thursday, August 14, 2025, at 6:15 PM
Location: Baltimore, MD
This highly anticipated symposium will feature leading experts in leptomeningeal metastases (LM), including:
- Peter Forsyth, M.D. – Moffitt Cancer Center
- Yoly Pina, Ph.D. – Moffitt Cancer Center
- Priya Kumthekar, M.D. – Northwestern University Feinberg School of Medicine
- Andrew Brenner, M.D., Ph.D. – UT Health San Antonio
- Isabella Glitza, M.D., Ph.D. – MD Anderson Cancer Center
What to Expect
The session will explore emerging strategies to improve the detection, monitoring, and management of LM, including:
- Real-world evidence from current clinical practice
- Clinical trial updates in diagnostics and radiotherapeutics
- Evolving perspectives on LM patient management
- Future directions for precision medicine in CNS cancers
This symposium provides a unique opportunity to learn directly from experts shaping the future of LM care.
Learn More and Register
For full details and registration, visit the SNO/ASCO CNS Metastases Conference website.
To request a recording of the symposium, please contact CNSide Diagnostics.
#CNSide #LeptomeningealMetastases #CNSMetastases #SNO2025 #ASCO #NeuroOncology #CancerDiagnostics #Radiotherapeutics #PrecisionMedicine #BrainCancer #ClinicalResearch
0 Comments